Use of nafamostat mesilate for anticoagulation during extracorporeal membrane oxygenation: A systematic review.
ARTIFICIAL ORGANS(2022)
Abstract
Anticoagulation with NM in ECMO has not been prospectively studied. While several centers have experience with this approach in high-risk patients, prospective studies are warranted to establish the optimal space of this approach in ECMO.
MoreTranslated text
Key words
ECMO,bleeding,cardiopulmonary bypass,heparin resistance,heparin-induced thrombocytopenia,thrombosis,unfractionated heparin
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined